-
1 . Academic Journal
Effect of tralokinumab, an interleukin-13 neutralising monoclonal antibody, on eosinophilic airway inflammation in uncontrolled moderate-to-severe asthma (MESOS): a multicentre, double-blind, randomised, placebo-controlled phase 2 trial
- 저자
- by Laviolette, Michel; Skjold, Tina; Nielsen, Læge Carl; Howarth, Peter; Russell, Richard J, et al.
- 소스
- In The Lancet Respiratory Medicine July 2018 6(7):499-510
-
7 . Periodical
Effect of tralokinumab, an interleukin-13 neutralising monoclonal antibody, on eosinophilic airway inflammation in uncontrolled moderate-to-severe asthma (MESOS): a multicentre, double-blind, randomised, placebo-controlled phase 2 trial
- 저자
- by Russell, Richard J; Chachi, Latifa; FitzGerald, J Mark; Backer, Vibeke; Olivenstein, Ronald, et al.
- 소스
- The Lancet Respiratory Medicine; July 2018, Vol. 6 Issue: 7 p499-510, 12p